Skip to content
Search

Latest Stories

Healthcare bodies call for mandatory masks in all healthcare settings in England

Various healthcare organisations from across England have written to the prime minister calling for face masks to be mandatory in all healthcare settings.

The wearing of face masks or coverings will no longer be a legal requirement in England from July 19, but prime minister Boris Johnson has said it will be a matter of “personal responsibility”.


The letter -- jointly signed by the Royal Pharmaceutical Society, the British Medical Association, British Dental Association, Royal College of Nursing and the College of Optometrists -- calls for mandatory use of face masks, social distancing and regular handwashing by the public to stay in place in all healthcare settings beyond the government's July 19 'freedom day'.

The signatories have also asked for the use of appropriate respiratory protection for healthcare staff and improvements in ventilation wherever it is required.

Thorrun Govind, chair of RPS in England, said: “Using masks in healthcare environments means staff and the public are taking steps to protect each other from Covid-19. It should, therefore, remain mandatory that they are worn past July 19.

“Despite some pharmacies being in retail environments, they remain a healthcare setting and have been relied upon to support and protect the public over the past 18 months.

“We are therefore calling on the government to make a decision to support and protect pharmacists and healthcare professionals, as well as the public.”

Dr Chaand Nagpaul, chair of BMA Council, said: “Scrapping the remaining restrictions next week – when a significant proportion of the population still has not been fully vaccinated – will give this deadly virus an opportunity to retighten its grip; pushing infection rates up, increasing hospitalisations and people ill with long-Covid, risking new vaccine-resistant variants developing, and putting more lives at unnecessary risk.

“While the government has said it will continue to encourage the wearing of face coverings after the 19th, within the same breath ministers confirm that masks will not be mandatory. This is contradictory and shows the government absolving itself of responsibility while heaping pressure on the public, confused by mixed messaging of the highest order. Ministers must now reassess the decision to lift the remaining restrictions on July 19. Until then, we urge the public to continue taking every precaution by wearing face coverings, maintaining social distancing, and meeting outside where possible.”

British Dental Association chair Eddie Crouch said: “No health professional should be left struggling to manage patient expectations come Monday.

“After all the mixed messages we need government to be crystal clear that face coverings will remain in place to protect the public and staff.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less